Get started
Author

Erika Patricia Azorin‐Vega

Observed names: Azorin-Vega Erika, E. Azorín-Vega, E. Azorín-Vega, E.P. Azorín-Vega, Erika Azorín-Vega, Erika Azorín, Erika Azorín-Vega, Erika Azorín‐Vega, Erika P. Azorin-Vega, Erika P. Azorín-Vega, Erika Patricia Azorin Vega, Erika Patricia Azorin-Vega, Erika Patricia Azorin-Vega,, Erika Patricia Azorín Vega, Erika Patricia Azorín-Vega
ORCID: 0000-0002-7520-461X
Observed ORCID: 0000-0002-7520-461X
OpenAlex ID: A5084445648
Multifunctional targeted therapy system based on 99mTc/177Lu‐labeled gold nanoparticles‐Tat(49–57)‐Lys3‐bombesin internalized in nuclei of prostate cancer cells
2013 · Nallely Jiménez‐Mancilla, Guillermina Ferro‐Flores, et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 88
Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT
2017 · Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, et al. · Nuclear Medicine and Biology · 82
177Lu-Dendrimer Conjugated to Folate and Bombesin with Gold Nanoparticles in the Dendritic Cavity: A Potential Theranostic Radiopharmaceutical
2016 · Héctor Mendoza-Nava, Guillermina Ferro-Flores, et al. · Journal of Nanomaterials · 73
PDF
Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177 Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells
2017 · Héctor Mendoza-Nava, Guillermina Ferro-Flores, et al. · Molecular Imaging · 50
Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
2022 · Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, et al. · Molecules · 45
PDF
Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
2013 · G. Ferro-Flores, B. Ocampo-García, et al. · Current Medicinal Chemistry · 45
Effect of extracellular matrix on adhesion, viability, actin cytoskeleton and K+ currents of cells expressing human ether à go-go channels
2007 · Claudia Toral, M. Eugenia Mendoza-Garrido, et al. · Life Sciences · 40
Synthesis and evaluation of Lys 1 (α,γ-Folate)Lys 3 ( 177 Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer
2015 · Liliana Aranda-Lara, Guillermina Ferro-Flores, et al. · Applied Radiation and Isotopes · 32
Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with 177Lu and Conjugated to Peptides
2015 · Guillermina Ferro-Flores, Blanca Ocampo-García, et al. · Current Radiopharmaceuticals · 32
A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells
2017 · Myrna Luna-Gutiérrez, Guillermina Ferro-Flores, et al. · Journal of the Mexican Chemical Society · 30
PDF
[99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities
2022 · Paola Vallejo-Armenta, Guillermina Ferro-Flores, et al. · Pharmaceuticals · 28
PDF
177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer
2018 · Clara Santos-Cuevas, Guillermina Ferro-Flores, et al. · Contrast Media & Molecular Imaging · 27
PDF
Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging
2014 · Emmanuel Orocio-Rodríguez, Guillermina Ferro-Flores, et al. · Journal of Nanoscience and Nanotechnology · 27
Synthesis and preclinical evaluation of the 99mTc-/177Lu-CXCR4-L theranostic pair for in vivo chemokine-4 receptor-specific targeting
2020 · Marcela Ávila-Sánchez, Guillermina Ferro-Flores, et al. · Journal of Radioanalytical and Nuclear Chemistry · 21
Assessment of the radiation absorbed dose produced by 177Lu-iPSMA, 225Ac-iPSMA and 223RaCl2 to prostate cancer cell nuclei in a bone microenvironment model
2019 · Erika Azorín-Vega, Eva Rojas-Calderón, et al. · Applied Radiation and Isotopes · 21
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose
2025 · Guillermina Ferro-Flores, Erika Azorín-Vega, et al. · International Journal of Molecular Sciences · 17
PDF
Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy
2023 · Myrna Luna-Gutiérrez, Pedro Cruz-Nova, et al. · International Journal of Molecular Sciences · 16
PDF
177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: synthesis and assessment of the ability to target the prostate specific membrane antigen
2018 · Tania Hernández-Jiménez, Guillermina Ferro-Flores, et al. · Journal of Radioanalytical and Nuclear Chemistry · 15
Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy
2025 · Myrna Luna-Gutiérrez, Erika Azorín-Vega, et al. · EJNMMI Radiopharmacy and Chemistry · 13
PDF
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
2024 · Laura De Nardo, Sara Santi, et al. · EJNMMI Physics · 13
PDF
99mTc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans
2020 · Paola Vallejo-Armenta, Clara Santos-Cuevas, et al. · Contrast Media & Molecular Imaging · 13
PDF
The invasion mode of GH3 cells is conditioned by collagen subtype, and its efficiency depends on cell–cell adhesion
2012 · Erika Azorín, Carmen Solano-Agama, et al. · Archives of Biochemistry and Biophysics · 13
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe
2023 · Guillermina Ferro-Flores, Blanca Ocampo-García, et al. · Pharmaceutics · 12
PDF
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses
2023 · Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, et al. · Pharmaceutics · 12
PDF
Synthesis and Biochemical Evaluation of Samarium-153 Oxide Nanoparticles Functionalized with iPSMA-Bombesin Heterodimeric Peptide
2020 · D. Trujillo-Benítez, G. Ferro-Flores, et al. · Journal of Biomedical Nanotechnology · 12
Works count: 65
Citation count: 887
H-index: 16
I10-index: 28
Year
Topic
Type